What Wall Street is watching
Investors want to know if Eli Lilly is experiencing the same pricing pressures on its blockbuster weight-loss drug Zepbound that…
amgen inc
These drugmakers are catching up to Eli Lilly and Novo Nordisk
The lucrative market for weight-loss drugs won’t be a duopoly forever. With billions at stake, that’s been a virtual guarantee…
Fund manager of names in weight loss and biotechnology
Weight-loss drugs have sparked investor interest and shaken up other sectors over the past year. Novo Nordisk and Eli Lilly…
Investors could see evidence in H2 of AI's assistance in drug discovery
As investors look to the future to imagine which industries are ripe to be reshaped and energized by artificial intelligence,…
AstraZeneca will increase its revenues and launch new drugs by 2030
Astrazeneca's logo appears at the 2021 World Artificial Intelligence Conference in Shanghai, China on July 7, 2021. Costofoto | Future…
FDA approves Amgen's small cell lung cancer treatment
Amgen's headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | fake images The Food and Drug Administration on Thursday…
Amgen scraps experimental weight-loss pill, moves forward with shot
The Amgen logo is displayed outside of Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama |…
Amgen Soars on Progress in Weight-Loss Drugs, Novo Nordisk and Eli Lilly Fall
amgenShares rose more than 12% on Friday after the drugmaker revealed positive initial data on its experimental weight-loss shot. That…
Johnson & Johnson (JNJ) earnings in the first quarter of 2024
An entrance sign to the Johnson & Johnson campus displays its logo in Irvine, California, on August 28, 2019. Marcos…
Novo Nordisk and Eli Lilly address supply issues
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…